Taheritafti 2019.
Study characteristics | ||
Methods | Single‐centre, randomised controlled trial conducted in Iran | |
Participants |
Inclusion criteria: term infants (gestational age ≥ 37 weeks); (quote:) "non‐haemolytic hyperbilirubinaemia" Exclusion criteria: haemolytic anaemia; prematurity; sepsis; severe hyperbilirubinaemia (total bilirubin > 18 mg/dL); conjugated hyperbilirubinaemia; onset of jaundice within first 24 hours of life |
|
Interventions | Total N = 60 Group 1 (n = 30): continuous phototherapy Group 2 (n = 30): intermittent phototherapy (18 hours on, 8 hours off) Phototherapy was continued until total serum bilirubin < 11 mg/dL (breaks up to 1 hour allowed during breastfeeding, changing and changing of diapers (both groups)) |
|
Outcomes |
Primary outcomes
Secondary outcomes
Other reported outcomes
|
|
Notes | IRCT registration number: IRCT2015112225184N1 | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Quote: "neonates via block randomization were divided into two groups". |
Allocation concealment (selection bias) | Unclear risk | Allocation concealment not described |
Blinding (performance bias and detection bias) All outcomes | Low risk | Unblinded study with objective outcome measures |
Blinding of participants and personnel (performance bias) All outcomes | Low risk | Unblinded study with objective outcome measures |
Blinding of outcome assessment (detection bias) All outcomes | Low risk | Unblinded study with objective outcome measures |
Incomplete outcome data (attrition bias) All outcomes | Low risk | Complete outcome data provided for all infants |
Selective reporting (reporting bias) | High risk | Reported bilirubin levels at different time points to prespecified time points in trial registry; trial registered during recruitment phase |
Other bias | Low risk | No other potential sources of bias were identified. |